How does Sitagliptin compare to GLP-1 receptor agonists for managing weight and glycemic control in patients with comorbid obesity?
Sunil JoshiExplorer
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
How does Sitagliptin compare to GLP-1 receptor agonists for managing weight and glycemic control in patients with comorbid obesity?
Sitagliptin, a DPP-4 inhibitor, generally has a neutral effect on weight, whereas GLP-1 receptor agonists often promote significant weight loss and generally provide better glycemic control.